Search

Keywords: Health and Medicine; Risk and Prevention EN Health and Medicine Risk and Prevention 5648 5648 1 08/07/23 20230811 NES 230811 2023 AUG 11 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators discuss new findings in agriculture. According to the news reporters, the research concluded: "On the other hand, the odds of preterm births among uninsured US-born Latinx birthing people did not significantly increase after the publication of the proposed rule compared with privately insured US-born Latinx birthing people. [Extracted from the article]

A recent study conducted at the University of Michigan focused on identifying biomarkers for predicting post-CAR-T cytopenias in patients undergoing CAR-T cell therapy for hematological malignancies. The research analyzed proteomics data from plasma samples of patients before and after CAR-T infusion, identifying potential biomarkers associated with cytopenia development. The study highlighted dysregulation of innate immunity and Wnt signaling as areas for further investigation in understanding post-CAR-T cytopenias. This research provides valuable insights for future studies and potential therapeutic targets in managing cytopenias post-CAR-T therapy. [Extracted from the article]

A recent study conducted by researchers at Pennsylvania State University College of Medicine examined the timing of treatment for opioid use disorder (OUD) among pregnant individuals. The study found that the number of pregnant women with OUD has increased over time, but little is known about when treatment is initiated during pregnancy. The researchers used a national private health insurance claims database to analyze data from women aged 13-49 who gave birth between 2006 and 2019. They found that rates of OUD treatment increased from 42.9% in 2006 to 69% in 2019, and more women initiated treatment prior to conception. However, over one-third of pregnant women with OUD did not receive treatment or initiate care until the third trimester in 2019. The study suggests that future research should focus on identifying barriers to treatment initiation among pregnant women. [Extracted from the article]

A recent study conducted by researchers at the University of Michigan explored the use of resistant potato starch (RPS) as a prebiotic dietary intervention in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HCT). The study aimed to assess the feasibility and impact of RPS on the patients' intestinal microbiota and its dependent metabolites. The results showed that RPS was feasible and increased stool butyrate levels, a beneficial microbial metabolite. The study suggests that RPS could be a potential strategy to mitigate acute graft-versus-host disease (GVHD) in allo-HCT recipients. [Extracted from the article]

A recent report from Harvard Medical School presents new data on stem cell transplants. The study compared two different treatments for graft-versus-host disease (GVHD) prophylaxis after hematopoietic cell transplant (HCT). The researchers found that post-transplant cyclophosphamide (PT-Cy) significantly improved GVHD-free Relapse-Free Survival compared to the other treatment, but overall survival was not significantly different. The study also revealed that PT-Cy led to a less diverse T cell repertoire, which has implications for both the efficacy and toxicity of the treatment. The findings suggest a novel mechanism for controlling GVHD with PT-Cy but also increase the risk of infections. [Extracted from the article]

Charleston, State:South Carolina, United States, North and Central America, Biomarkers, Biomedicine, Cell Transplants, Diagnostics and Screening, Health and Medicine, Hematology, Hematopoietic, Cell Transplantation, Risk and Prevention, Stem Cell Transplants, Surgery, Transplant Medicine Keywords: Charleston; State:South Carolina; United States; North and Central America; Biomarkers; Biomedicine; Cell Transplantation; Cell Transplants; Diagnostics and Screening; Health and Medicine; Hematology; Hematopoietic; Risk and Prevention; Stem Cell Transplants; Surgery; Transplant Medicine EN Charleston State:South Carolina United States North and Central America Biomarkers Biomedicine Cell Transplantation Cell Transplants Diagnostics and Screening Health and Medicine Hematology Hematopoietic Risk and Prevention Stem Cell Transplants Surgery Transplant Medicine 216 216 1 07/03/23 20230706 NES 230706 2023 JUL 6 (NewsRx) -- By a News Reporter-Staff News Editor at Blood Weekly -- New research on Transplant Medicine - Stem Cell Transplants is the subject of a report. [Extracted from the article]